Factors Associated With Disparities in Hospital Readmission Rates Among US Adults Dually Eligible for Medicare and Medicaid.


Journal

JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500

Informations de publication

Date de publication:
01 2022
Historique:
received: 26 07 2021
accepted: 02 11 2021
entrez: 17 8 2022
pubmed: 18 8 2022
medline: 18 8 2022
Statut: epublish

Résumé

Low-income older adults who are dually eligible (DE) for Medicare and Medicaid often experience worse outcomes following hospitalization. Among other federal policies aimed at improving health for DE patients, Medicare has recently begun reporting disparities in within-hospital readmissions. The degree to which disparities for DE patients are owing to differences in community-level factors or, conversely, are amenable to hospital quality improvement, remains heavily debated. To examine the extent to which within-hospital disparities in 30-day readmission rates for DE patients are ameliorated by state- and community-level factors. In this retrospective cohort study, Centers for Medicare & Medicaid Services (CMS) Disparity Methods were used to calculate within-hospital disparities in 30-day risk-adjusted readmission rates for DE vs non-DE patients in US hospitals participating in Medicare. All analyses were performed in February and March 2019. The study included Medicare patients (aged ≥65 years) hospitalized for acute myocardial infarction (AMI), heart failure (HF), or pneumonia in 2014 to 2017. Within-hospital disparities, as measured by the rate difference (RD) in 30-day readmission between DE vs non-DE patients following admission for AMI, HF, or pneumonia; variance across hospitals; and correlation of hospital RDs with and without adjustment for state Medicaid eligibility policies and community-level factors. The final sample included 475 444 patients admitted for AMI, 898 395 for HF, and 1 214 282 for pneumonia, of whom 13.2%, 17.4%, and 23.0% were DE patients, respectively. Dually eligible patients had higher 30-day readmission rates relative to non-DE patients (RD >0) in 99.0% (AMI), 99.4% (HF), and 97.5% (pneumonia) of US hospitals. Across hospitals, the mean (IQR) RD between DE vs non-DE was 1.00% (0.87%-1.10%) for AMI, 0.82% (0.73%-0.96%) for HF, and 0.53% (0.37%-0.71%) for pneumonia. The mean (IQR) RD after adjustment for community-level factors was 0.87% (0.73%-0.97%) for AMI, 0.67% (0.57%-0.80%) for HF, and 0.42% (0.29%-0.57%) for pneumonia. Relative hospital rankings of corresponding within-hospital disparities before and after community-level adjustment were highly correlated (Pearson coefficient, 0.98). In this cohort study, within-hospital disparities in 30-day readmission for DE patients were modestly associated with differences in state Medicaid policies and community-level factors. This suggests that remaining variation in these disparities should be the focus of hospital efforts to improve the quality of care transitions at discharge for DE patients in efforts to advance equity.

Identifiants

pubmed: 35977231
doi: 10.1001/jamahealthforum.2021.4611
pii: aoi210078
pmc: PMC8903116
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Pagination

e214611

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL155425
Pays : United States

Informations de copyright

Copyright 2022 Silvestri D et al. JAMA Health Forum.

Déclaration de conflit d'intérêts

Conflict of Interest Disclosures: Dr Silvestri is currently employed by NYC Health and Hospitals but completed this work at Yale University while supported in part through CTSA Grant Number TL1 TR001864 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). Drs Peltz, Lloren, Zhou S, Zhou G, Farietta, Herrin, Lin, and Bernheim, Ms Charania, and Mr Goutos completed this work while working as employees or consultants at Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation (YNHHSC/CORE). This work was supported by the Centers for Medicare & Medicaid Services (CMS) under contract HHSM-500-2013-13018I/HHSM-500-T0001.

Références

JAMA Intern Med. 2015 Apr;175(4):559-65
pubmed: 25642907
J Gen Intern Med. 2017 Jan;32(1):71-80
pubmed: 27848189
JAMA Cardiol. 2021 Jul 1;6(7):791-800
pubmed: 33825802
JAMA Pediatr. 2016 Apr;170(4):350-8
pubmed: 26881387
Health Serv Res. 2019 Feb;54 Suppl 1:243-254
pubmed: 30666634
JAMA Intern Med. 2015 Nov;175(11):1803-12
pubmed: 26368317
Health Aff (Millwood). 2014 May;33(5):786-91
pubmed: 24799575
J Am Heart Assoc. 2014 May 20;3(3):e000714
pubmed: 24847032
Health Serv Res. 2019 Dec;54(6):1233-1245
pubmed: 31576563
Health Serv Res. 2014 Jun;49(3):818-37
pubmed: 24417309
Health Serv Res. 2018 Dec;53(6):4416-4436
pubmed: 30151882
BMJ Qual Saf. 2020 Mar;29(3):232-237
pubmed: 31540969
Health Aff (Millwood). 2013 Oct;32(10):1731-9
pubmed: 24101062
Health Serv Res. 2015 Feb;50(1):20-39
pubmed: 24712374
Am J Epidemiol. 2006 Sep 15;164(6):586-90
pubmed: 16893922
BMJ Open. 2017 Jul 13;7(7):e016149
pubmed: 28710221
Qual Manag Health Care. 2014 Jan-Mar;23(1):20-42
pubmed: 24368719
JAMA Netw Open. 2018 Sep 7;1(5):e182044
pubmed: 30646146
JAMA Intern Med. 2018 Nov 1;178(11):1498-1507
pubmed: 30242346
Health Aff (Millwood). 2014 May;33(5):778-85
pubmed: 24799574
Health Aff (Millwood). 2016 Jan;35(1):124-31
pubmed: 26733710
Am J Med Sci. 2016 Apr;351(4):366-73
pubmed: 27079342

Auteurs

David Silvestri (D)

National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut.
Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.

Demetri Goutos (D)

The Yale Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut.

Anouk Lloren (A)

Mathematica Policy Research, Cambridge, Massachusetts.

Sheng Zhou (S)

Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.
The Yale Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut.

Guohai Zhou (G)

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Thalia Farietta (T)

Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.

Sana Charania (S)

Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University, Washington, DC.

Jeph Herrin (J)

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Flying Buttress Associates, Charlottesville, Virginia.

Alon Peltz (A)

The Yale Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut.
Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Zhenqiu Lin (Z)

The Yale Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut.
Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.

Susannah Bernheim (S)

National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut.
The Yale Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut.
Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH